396 related articles for article (PubMed ID: 27235866)
21. PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease.
Fleck D; Phu L; Verschueren E; Hinkle T; Reichelt M; Bhangale T; Haley B; Wang Y; Graham R; Kirkpatrick DS; Sheng M; Bingol B
J Neurosci; 2019 Jun; 39(24):4636-4656. PubMed ID: 30948477
[TBL] [Abstract][Full Text] [Related]
22. Caveolin-1 scaffolding domain peptide regulates glucose metabolism in lung fibrosis.
Gopu V; Fan L; Shetty RS; Nagaraja MR; Shetty S
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32841217
[TBL] [Abstract][Full Text] [Related]
23. Circular HDAC9/microRNA-138/Sirtuin-1 Pathway Mediates Synaptic and Amyloid Precursor Protein Processing Deficits in Alzheimer's Disease.
Lu Y; Tan L; Wang X
Neurosci Bull; 2019 Oct; 35(5):877-888. PubMed ID: 30887246
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of
Zhang Y; Liu G; Gao X
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28894025
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.
Beckelman BC; Day S; Zhou X; Donohue M; Gouras GK; Klann E; Keene CD; Ma T
J Alzheimers Dis; 2016 Sep; 54(2):669-78. PubMed ID: 27567813
[TBL] [Abstract][Full Text] [Related]
26. miR-34a in Neurophysiology and Neuropathology.
Chua CEL; Tang BL
J Mol Neurosci; 2019 Feb; 67(2):235-246. PubMed ID: 30488149
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model.
Kong Y; Wu J; Yuan L
Curr Alzheimer Res; 2014; 11(9):882-91. PubMed ID: 25274109
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Effects of Transplantation of As-MiR-937-Expressing Mesenchymal Stem Cells in Murine Model of Alzheimer's Disease.
Liu Z; Wang C; Wang X; Xu S
Cell Physiol Biochem; 2015; 37(1):321-30. PubMed ID: 26316079
[TBL] [Abstract][Full Text] [Related]
30. RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.
Nunomura A; Perry G
Oxid Med Cell Longev; 2020; 2020():2638130. PubMed ID: 33312335
[TBL] [Abstract][Full Text] [Related]
31. Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder.
Bavamian S; Mellios N; Lalonde J; Fass DM; Wang J; Sheridan SD; Madison JM; Zhou F; Rueckert EH; Barker D; Perlis RH; Sur M; Haggarty SJ
Mol Psychiatry; 2015 May; 20(5):573-84. PubMed ID: 25623948
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-132 promotes neurons cell apoptosis and activates Tau phosphorylation by targeting GTDC-1 in Alzheimer's disease.
Liu DY; Zhang L
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8523-8532. PubMed ID: 31646584
[TBL] [Abstract][Full Text] [Related]
33. miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q.
Xu N; Li AD; Ji LL; Ye Y; Wang ZY; Tong L
Eur J Histochem; 2019 May; 63(2):. PubMed ID: 31060348
[TBL] [Abstract][Full Text] [Related]
34. GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease.
Zheng J; Xie Y; Ren L; Qi L; Wu L; Pan X; Zhou J; Chen Z; Liu L
Mol Metab; 2021 May; 47():101180. PubMed ID: 33556642
[TBL] [Abstract][Full Text] [Related]
35. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
Wang H; Liu J; Zong Y; Xu Y; Deng W; Zhu H; Liu Y; Ma C; Huang L; Zhang L; Qin C
Brain Res; 2010 Oct; 1357():166-74. PubMed ID: 20709030
[TBL] [Abstract][Full Text] [Related]
36. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model.
Guedes JR; Custódia CM; Silva RJ; de Almeida LP; Pedroso de Lima MC; Cardoso AL
Hum Mol Genet; 2014 Dec; 23(23):6286-301. PubMed ID: 24990149
[TBL] [Abstract][Full Text] [Related]
37. Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease.
Wang LL; Min L; Guo QD; Zhang JX; Jiang HL; Shao S; Xing JG; Yin LL; Liu JH; Liu R; Guo SL
Biomed Res Int; 2017; 2017():8030369. PubMed ID: 29057267
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
39. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology.
Sierksma A; Lu A; Salta E; Vanden Eynden E; Callaerts-Vegh Z; D'Hooge R; Blum D; Buée L; Fiers M; De Strooper B
Mol Neurodegener; 2018 Oct; 13(1):54. PubMed ID: 30314521
[TBL] [Abstract][Full Text] [Related]
40. miR-146a Dysregulates Energy Metabolism During Neuroinflammation.
Kim SJ; Russell AE; Wang W; Gemoets DE; Sarkar SN; Simpkins JW; Brown CM
J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):228-241. PubMed ID: 34028667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
